1 Market Overview

1.1 Product Overview and Scope of Infectious Disease Point of Care Diagnostics

1.2 Classification of Infectious Disease Point of Care Diagnostics by Type

1.2.1 Overview: Global Infectious Disease Point of Care Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type in 2021

1.2.3 Over-the-counter (OTC) Testing Kits

1.2.4 Prescription-based Testing Kits

1.3 Global Infectious Disease Point of Care Diagnostics Market by Application

1.3.1 Overview: Global Infectious Disease Point of Care Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Bacterial Infections

1.3.3 Fungal Infection

1.3.4 Virus Infection

1.3.5 Cardiovascular Infection

1.3.6 Gastrointestinal Infection

1.3.7 Sexually Transmitted Disease (STD) Infection

1.3.8 Central Nervous System Infection

1.3.9 Other

1.4 Global Infectious Disease Point of Care Diagnostics Market Size & Forecast

1.5 Global Infectious Disease Point of Care Diagnostics Market Size and Forecast by Region

1.5.1 Global Infectious Disease Point of Care Diagnostics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Infectious Disease Point of Care Diagnostics Market Size by Region, (2017-2022)

1.5.3 North America Infectious Disease Point of Care Diagnostics Market Size and Prospect (2017-2028)

1.5.4 Europe Infectious Disease Point of Care Diagnostics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size and Prospect (2017-2028)

1.5.6 South America Infectious Disease Point of Care Diagnostics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Infectious Disease Point of Care Diagnostics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Infectious Disease Point of Care Diagnostics Market Drivers

1.6.2 Infectious Disease Point of Care Diagnostics Market Restraints

1.6.3 Infectious Disease Point of Care Diagnostics Trends Analysis

2 Company Profiles

2.1 Abbott

2.1.1 Abbott Details

2.1.2 Abbott Major Business

2.1.3 Abbott Infectious Disease Point of Care Diagnostics Product and Solutions

2.1.4 Abbott Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Abbott Recent Developments and Future Plans

2.2 Siemens

2.2.1 Siemens Details

2.2.2 Siemens Major Business

2.2.3 Siemens Infectious Disease Point of Care Diagnostics Product and Solutions

2.2.4 Siemens Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Siemens Recent Developments and Future Plans

2.3 GE Healthcare

2.3.1 GE Healthcare Details

2.3.2 GE Healthcare Major Business

2.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Product and Solutions

2.3.4 GE Healthcare Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 GE Healthcare Recent Developments and Future Plans

2.4 Accriva

2.4.1 Accriva Details

2.4.2 Accriva Major Business

2.4.3 Accriva Infectious Disease Point of Care Diagnostics Product and Solutions

2.4.4 Accriva Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Accriva Recent Developments and Future Plans

2.5 Terumo

2.5.1 Terumo Details

2.5.2 Terumo Major Business

2.5.3 Terumo Infectious Disease Point of Care Diagnostics Product and Solutions

2.5.4 Terumo Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Terumo Recent Developments and Future Plans

2.6 BioMerieux

2.6.1 BioMerieux Details

2.6.2 BioMerieux Major Business

2.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Product and Solutions

2.6.4 BioMerieux Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 BioMerieux Recent Developments and Future Plans

2.7 Diasorin

2.7.1 Diasorin Details

2.7.2 Diasorin Major Business

2.7.3 Diasorin Infectious Disease Point of Care Diagnostics Product and Solutions

2.7.4 Diasorin Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Diasorin Recent Developments and Future Plans

2.8 Roche

2.8.1 Roche Details

2.8.2 Roche Major Business

2.8.3 Roche Infectious Disease Point of Care Diagnostics Product and Solutions

2.8.4 Roche Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Roche Recent Developments and Future Plans

2.9 Danaher Corporation

2.9.1 Danaher Corporation Details

2.9.2 Danaher Corporation Major Business

2.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Product and Solutions

2.9.4 Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Danaher Corporation Recent Developments and Future Plans

2.10 BD

2.10.1 BD Details

2.10.2 BD Major Business

2.10.3 BD Infectious Disease Point of Care Diagnostics Product and Solutions

2.10.4 BD Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 BD Recent Developments and Future Plans

2.11 Bio-Rad Laboratories

2.11.1 Bio-Rad Laboratories Details

2.11.2 Bio-Rad Laboratories Major Business

2.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product and Solutions

2.11.4 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Bio-Rad Laboratories Recent Developments and Future Plans

2.12 Cavidi

2.12.1 Cavidi Details

2.12.2 Cavidi Major Business

2.12.3 Cavidi Infectious Disease Point of Care Diagnostics Product and Solutions

2.12.4 Cavidi Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Cavidi Recent Developments and Future Plans

2.13 Cepheid

2.13.1 Cepheid Details

2.13.2 Cepheid Major Business

2.13.3 Cepheid Infectious Disease Point of Care Diagnostics Product and Solutions

2.13.4 Cepheid Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Cepheid Recent Developments and Future Plans

2.14 Diaxonhit

2.14.1 Diaxonhit Details

2.14.2 Diaxonhit Major Business

2.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Product and Solutions

2.14.4 Diaxonhit Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Diaxonhit Recent Developments and Future Plans

2.15 Eiken Chemical

2.15.1 Eiken Chemical Details

2.15.2 Eiken Chemical Major Business

2.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Product and Solutions

2.15.4 Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Eiken Chemical Recent Developments and Future Plans

2.16 EMD Millipore

2.16.1 EMD Millipore Details

2.16.2 EMD Millipore Major Business

2.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Product and Solutions

2.16.4 EMD Millipore Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 EMD Millipore Recent Developments and Future Plans

2.17 Epitope Diagnostic

2.17.1 Epitope Diagnostic Details

2.17.2 Epitope Diagnostic Major Business

2.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product and Solutions

2.17.4 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Epitope Diagnostic Recent Developments and Future Plans

2.18 Euroimmun

2.18.1 Euroimmun Details

2.18.2 Euroimmun Major Business

2.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Product and Solutions

2.18.4 Euroimmun Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Euroimmun Recent Developments and Future Plans

2.19 Gold Standard Diagnostics

2.19.1 Gold Standard Diagnostics Details

2.19.2 Gold Standard Diagnostics Major Business

2.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product and Solutions

2.19.4 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 Gold Standard Diagnostics Recent Developments and Future Plans

2.20 Hologic

2.20.1 Hologic Details

2.20.2 Hologic Major Business

2.20.3 Hologic Infectious Disease Point of Care Diagnostics Product and Solutions

2.20.4 Hologic Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.20.5 Hologic Recent Developments and Future Plans

2.21 Immunetics

2.21.1 Immunetics Details

2.21.2 Immunetics Major Business

2.21.3 Immunetics Infectious Disease Point of Care Diagnostics Product and Solutions

2.21.4 Immunetics Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.21.5 Immunetics Recent Developments and Future Plans

2.22 InBios International

2.22.1 InBios International Details

2.22.2 InBios International Major Business

2.22.3 InBios International Infectious Disease Point of Care Diagnostics Product and Solutions

2.22.4 InBios International Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.22.5 InBios International Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Infectious Disease Point of Care Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Infectious Disease Point of Care Diagnostics Players Market Share in 2021

3.2.2 Top 10 Infectious Disease Point of Care Diagnostics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Infectious Disease Point of Care Diagnostics Players Head Office, Products and Services Provided

3.4 Infectious Disease Point of Care Diagnostics Mergers & Acquisitions

3.5 Infectious Disease Point of Care Diagnostics New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Infectious Disease Point of Care Diagnostics Revenue and Market Share by Type (2017-2022)

4.2 Global Infectious Disease Point of Care Diagnostics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Application (2017-2022)

5.2 Global Infectious Disease Point of Care Diagnostics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Infectious Disease Point of Care Diagnostics Revenue by Type (2017-2028)

6.2 North America Infectious Disease Point of Care Diagnostics Revenue by Application (2017-2028)

6.3 North America Infectious Disease Point of Care Diagnostics Market Size by Country

6.3.1 North America Infectious Disease Point of Care Diagnostics Revenue by Country (2017-2028)

6.3.2 United States Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

6.3.3 Canada Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

6.3.4 Mexico Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Infectious Disease Point of Care Diagnostics Revenue by Type (2017-2028)

7.2 Europe Infectious Disease Point of Care Diagnostics Revenue by Application (2017-2028)

7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Country

7.3.1 Europe Infectious Disease Point of Care Diagnostics Revenue by Country (2017-2028)

7.3.2 Germany Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

7.3.3 France Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

7.3.5 Russia Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

7.3.6 Italy Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Type (2017-2028)

8.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Application (2017-2028)

8.3 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region

8.3.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Region (2017-2028)

8.3.2 China Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

8.3.3 Japan Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

8.3.4 South Korea Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

8.3.5 India Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

8.3.7 Australia Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Infectious Disease Point of Care Diagnostics Revenue by Type (2017-2028)

9.2 South America Infectious Disease Point of Care Diagnostics Revenue by Application (2017-2028)

9.3 South America Infectious Disease Point of Care Diagnostics Market Size by Country

9.3.1 South America Infectious Disease Point of Care Diagnostics Revenue by Country (2017-2028)

9.3.2 Brazil Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

9.3.3 Argentina Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Type (2017-2028)

10.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Application (2017-2028)

10.3 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country

10.3.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Country (2017-2028)

10.3.2 Turkey Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

10.3.4 UAE Infectious Disease Point of Care Diagnostics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Infectious Disease Point of Care Diagnostics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Infectious Disease Point of Care Diagnostics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Infectious Disease Point of Care Diagnostics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Infectious Disease Point of Care Diagnostics Revenue (USD Million) by Region (2017-2022)

Table 5. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Region (2023-2028)

Table 6. Abbott Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Major Business

Table 8. Abbott Infectious Disease Point of Care Diagnostics Product and Solutions

Table 9. Abbott Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Siemens Corporate Information, Head Office, and Major Competitors

Table 11. Siemens Major Business

Table 12. Siemens Infectious Disease Point of Care Diagnostics Product and Solutions

Table 13. Siemens Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. GE Healthcare Corporate Information, Head Office, and Major Competitors

Table 15. GE Healthcare Major Business

Table 16. GE Healthcare Infectious Disease Point of Care Diagnostics Product and Solutions

Table 17. GE Healthcare Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Accriva Corporate Information, Head Office, and Major Competitors

Table 19. Accriva Major Business

Table 20. Accriva Infectious Disease Point of Care Diagnostics Product and Solutions

Table 21. Accriva Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Terumo Corporate Information, Head Office, and Major Competitors

Table 23. Terumo Major Business

Table 24. Terumo Infectious Disease Point of Care Diagnostics Product and Solutions

Table 25. Terumo Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. BioMerieux Corporate Information, Head Office, and Major Competitors

Table 27. BioMerieux Major Business

Table 28. BioMerieux Infectious Disease Point of Care Diagnostics Product and Solutions

Table 29. BioMerieux Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Diasorin Corporate Information, Head Office, and Major Competitors

Table 31. Diasorin Major Business

Table 32. Diasorin Infectious Disease Point of Care Diagnostics Product and Solutions

Table 33. Diasorin Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Roche Corporate Information, Head Office, and Major Competitors

Table 35. Roche Major Business

Table 36. Roche Infectious Disease Point of Care Diagnostics Product and Solutions

Table 37. Roche Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Danaher Corporation Corporate Information, Head Office, and Major Competitors

Table 39. Danaher Corporation Major Business

Table 40. Danaher Corporation Infectious Disease Point of Care Diagnostics Product and Solutions

Table 41. Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. BD Corporate Information, Head Office, and Major Competitors

Table 43. BD Major Business

Table 44. BD Infectious Disease Point of Care Diagnostics Product and Solutions

Table 45. BD Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors

Table 47. Bio-Rad Laboratories Major Business

Table 48. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product and Solutions

Table 49. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Cavidi Corporate Information, Head Office, and Major Competitors

Table 51. Cavidi Major Business

Table 52. Cavidi Infectious Disease Point of Care Diagnostics Product and Solutions

Table 53. Cavidi Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Cepheid Corporate Information, Head Office, and Major Competitors

Table 55. Cepheid Major Business

Table 56. Cepheid Infectious Disease Point of Care Diagnostics Product and Solutions

Table 57. Cepheid Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Diaxonhit Corporate Information, Head Office, and Major Competitors

Table 59. Diaxonhit Major Business

Table 60. Diaxonhit Infectious Disease Point of Care Diagnostics Product and Solutions

Table 61. Diaxonhit Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Eiken Chemical Corporate Information, Head Office, and Major Competitors

Table 63. Eiken Chemical Major Business

Table 64. Eiken Chemical Infectious Disease Point of Care Diagnostics Product and Solutions

Table 65. Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. EMD Millipore Corporate Information, Head Office, and Major Competitors

Table 67. EMD Millipore Major Business

Table 68. EMD Millipore Infectious Disease Point of Care Diagnostics Product and Solutions

Table 69. EMD Millipore Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Epitope Diagnostic Corporate Information, Head Office, and Major Competitors

Table 71. Epitope Diagnostic Major Business

Table 72. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product and Solutions

Table 73. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Euroimmun Corporate Information, Head Office, and Major Competitors

Table 75. Euroimmun Major Business

Table 76. Euroimmun Infectious Disease Point of Care Diagnostics Product and Solutions

Table 77. Euroimmun Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Gold Standard Diagnostics Corporate Information, Head Office, and Major Competitors

Table 79. Gold Standard Diagnostics Major Business

Table 80. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product and Solutions

Table 81. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. Hologic Corporate Information, Head Office, and Major Competitors

Table 83. Hologic Major Business

Table 84. Hologic Infectious Disease Point of Care Diagnostics Product and Solutions

Table 85. Hologic Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 86. Immunetics Corporate Information, Head Office, and Major Competitors

Table 87. Immunetics Major Business

Table 88. Immunetics Infectious Disease Point of Care Diagnostics Product and Solutions

Table 89. Immunetics Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 90. InBios International Corporate Information, Head Office, and Major Competitors

Table 91. InBios International Major Business

Table 92. InBios International Infectious Disease Point of Care Diagnostics Product and Solutions

Table 93. InBios International Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 94. Global Infectious Disease Point of Care Diagnostics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 95. Global Infectious Disease Point of Care Diagnostics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 96. Breakdown of Infectious Disease Point of Care Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 97. Infectious Disease Point of Care Diagnostics Players Head Office, Products and Services Provided

Table 98. Infectious Disease Point of Care Diagnostics Mergers & Acquisitions in the Past Five Years

Table 99. Infectious Disease Point of Care Diagnostics New Entrants and Expansion Plans

Table 100. Global Infectious Disease Point of Care Diagnostics Revenue (USD Million) by Type (2017-2022)

Table 101. Global Infectious Disease Point of Care Diagnostics Revenue Share by Type (2017-2022)

Table 102. Global Infectious Disease Point of Care Diagnostics Revenue Forecast by Type (2023-2028)

Table 103. Global Infectious Disease Point of Care Diagnostics Revenue by Application (2017-2022)

Table 104. Global Infectious Disease Point of Care Diagnostics Revenue Forecast by Application (2023-2028)

Table 105. North America Infectious Disease Point of Care Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 106. North America Infectious Disease Point of Care Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 107. North America Infectious Disease Point of Care Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 108. North America Infectious Disease Point of Care Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 109. North America Infectious Disease Point of Care Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 110. North America Infectious Disease Point of Care Diagnostics Revenue by Country (2023-2028) & (USD Million)

Table 111. Europe Infectious Disease Point of Care Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 112. Europe Infectious Disease Point of Care Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 113. Europe Infectious Disease Point of Care Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 114. Europe Infectious Disease Point of Care Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 115. Europe Infectious Disease Point of Care Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 116. Europe Infectious Disease Point of Care Diagnostics Revenue by Country (2023-2028) & (USD Million)

Table 117. Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 118. Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 119. Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 120. Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 121. Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Region (2017-2022) & (USD Million)

Table 122. Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Region (2023-2028) & (USD Million)

Table 123. South America Infectious Disease Point of Care Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 124. South America Infectious Disease Point of Care Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 125. South America Infectious Disease Point of Care Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 126. South America Infectious Disease Point of Care Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 127. South America Infectious Disease Point of Care Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 128. South America Infectious Disease Point of Care Diagnostics Revenue by Country (2023-2028) & (USD Million)

Table 129. Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 130. Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 131. Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 132. Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 133. Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 134. Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Infectious Disease Point of Care Diagnostics Picture

Figure 2. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type in 2021

Figure 3. Over-the-counter (OTC) Testing Kits

Figure 4. Prescription-based Testing Kits

Figure 5. Infectious Disease Point of Care Diagnostics Revenue Market Share by Application in 2021

Figure 6. Bacterial Infections Picture

Figure 7. Fungal Infection Picture

Figure 8. Virus Infection Picture

Figure 9. Cardiovascular Infection Picture

Figure 10. Gastrointestinal Infection Picture

Figure 11. Sexually Transmitted Disease (STD) Infection Picture

Figure 12. Central Nervous System Infection Picture

Figure 13. Other Picture

Figure 14. Global Infectious Disease Point of Care Diagnostics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 15. Global Infectious Disease Point of Care Diagnostics Revenue and Forecast (2017-2028) & (USD Million)

Figure 16. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Region (2017-2028)

Figure 17. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Region in 2021

Figure 18. North America Infectious Disease Point of Care Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Europe Infectious Disease Point of Care Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. South America Infectious Disease Point of Care Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. Middle East and Africa Infectious Disease Point of Care Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. Infectious Disease Point of Care Diagnostics Market Drivers

Figure 24. Infectious Disease Point of Care Diagnostics Market Restraints

Figure 25. Infectious Disease Point of Care Diagnostics Market Trends

Figure 26. Abbott Recent Developments and Future Plans

Figure 27. Siemens Recent Developments and Future Plans

Figure 28. GE Healthcare Recent Developments and Future Plans

Figure 29. Accriva Recent Developments and Future Plans

Figure 30. Terumo Recent Developments and Future Plans

Figure 31. BioMerieux Recent Developments and Future Plans

Figure 32. Diasorin Recent Developments and Future Plans

Figure 33. Roche Recent Developments and Future Plans

Figure 34. Danaher Corporation Recent Developments and Future Plans

Figure 35. BD Recent Developments and Future Plans

Figure 36. Bio-Rad Laboratories Recent Developments and Future Plans

Figure 37. Cavidi Recent Developments and Future Plans

Figure 38. Cepheid Recent Developments and Future Plans

Figure 39. Diaxonhit Recent Developments and Future Plans

Figure 40. Eiken Chemical Recent Developments and Future Plans

Figure 41. EMD Millipore Recent Developments and Future Plans

Figure 42. Epitope Diagnostic Recent Developments and Future Plans

Figure 43. Euroimmun Recent Developments and Future Plans

Figure 44. Gold Standard Diagnostics Recent Developments and Future Plans

Figure 45. Hologic Recent Developments and Future Plans

Figure 46. Immunetics Recent Developments and Future Plans

Figure 47. InBios International Recent Developments and Future Plans

Figure 48. Global Infectious Disease Point of Care Diagnostics Revenue Share by Players in 2021

Figure 49. Infectious Disease Point of Care Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 50. Global Top 3 Players Infectious Disease Point of Care Diagnostics Revenue Market Share in 2021

Figure 51. Global Top 10 Players Infectious Disease Point of Care Diagnostics Revenue Market Share in 2021

Figure 52. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 53. Global Infectious Disease Point of Care Diagnostics Revenue Share by Type in 2021

Figure 54. Global Infectious Disease Point of Care Diagnostics Market Share Forecast by Type (2023-2028)

Figure 55. Global Infectious Disease Point of Care Diagnostics Revenue Share by Application in 2021

Figure 56. Global Infectious Disease Point of Care Diagnostics Market Share Forecast by Application (2023-2028)

Figure 57. North America Infectious Disease Point of Care Diagnostics Sales Market Share by Type (2017-2028)

Figure 58. North America Infectious Disease Point of Care Diagnostics Sales Market Share by Application (2017-2028)

Figure 59. North America Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2017-2028)

Figure 60. United States Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Canada Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Mexico Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Europe Infectious Disease Point of Care Diagnostics Sales Market Share by Type (2017-2028)

Figure 64. Europe Infectious Disease Point of Care Diagnostics Sales Market Share by Application (2017-2028)

Figure 65. Europe Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2017-2028)

Figure 66. Germany Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. France Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. United Kingdom Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Russia Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Italy Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Asia-Pacific Infectious Disease Point of Care Diagnostics Sales Market Share by Type (2017-2028)

Figure 72. Asia-Pacific Infectious Disease Point of Care Diagnostics Sales Market Share by Application (2017-2028)

Figure 73. Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue Market Share by Region (2017-2028)

Figure 74. China Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Japan Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. South Korea Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. India Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Southeast Asia Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Australia Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. South America Infectious Disease Point of Care Diagnostics Sales Market Share by Type (2017-2028)

Figure 81. South America Infectious Disease Point of Care Diagnostics Sales Market Share by Application (2017-2028)

Figure 82. South America Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2017-2028)

Figure 83. Brazil Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 84. Argentina Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 85. Middle East and Africa Infectious Disease Point of Care Diagnostics Sales Market Share by Type (2017-2028)

Figure 86. Middle East and Africa Infectious Disease Point of Care Diagnostics Sales Market Share by Application (2017-2028)

Figure 87. Middle East and Africa Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2017-2028)

Figure 88. Turkey Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 89. Saudi Arabia Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 90. UAE Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 91. Methodology

Figure 92. Research Process and Data Source